'You still have to work with it': Campaigner warns weight loss drugs are not a 'quick-fix solution' 

Eli Lilly said trials showed the key ingredient in Mounjaro — tirzepatide — is more effective than the more well-known semalglutide found in drugs such as Ozempic or Wegovy. File picture

The makers of obesity treatment Mounjaro, known as the 'King Kong' of obesity drugs, have now applied to the HSE to have it considered for public patients.

Eli Lilly had already said it expected to make Mounjaro available in Ireland for private prescription in early 2025. A spokeswoman told the Irish Examiner it has now applied for reimbursement.